ESPE Abstracts (2022) 95 P1-421

ESPE2022 Poster Category 1 Bone, Growth Plate and Mineral Metabolism (46 abstracts)

Novel ACAN Variants in Eight Chinese Families with Short Stature and Literature Review

Shuyun Deng 1 , Lele Hou 2 , Dan Xia 1 , Xiaojuan Li 1 , Nengtai Ouyang 1 & Liyang Liang 2

1Cellular & Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 2Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

Context: ACAN gene is located at 15q26.1 and encodes aggrecan, which is a critical proteoglycan component of cartilage extracellular matrix. Heterozygous variants in ACAN are associated with short stature, premature growth cessation, and impaired bone maturation. A comprehensive understanding of the genetic and clinical characteristics of patients with ACAN mutations helps to improve the overall management of an individual.

Objective: We sought to analyze eight Chinese short stature children with heterozygous ACAN mutations and perform a literature search to firstly summarize the phenotypic spectrum, secondly elucidate the effects of age, sex and mutation type on the height of ACAN mutations carriers, and finally investigate the treatment outcome of growth-promoting therapy.

Patients and Methods: Eight probands from unrelated families were genetically evaluated by Whole-Exome Sequencing (WES). Subsequently, we reviewed the literature to summarize the clinical characteristics, genetic findings, and the efficacy of growth-promoting therapy in ACAN-positive individuals.

Results: We identified seven novel ACAN mutations and one recurrent variant. Patients in our center showed somewhat hypertelorism (4/8), broad nose (4/8), long philtrum (2/8), flat nasal bridge (2/8), brachydactyly (1/8) and short neck (1/8). Besides, the variants in the ACAN gene might display high penetrance. Combined with the literature review, we found that Hands/feet deformity (50%), spinal deformity (36.26%), and head/neck deformity (30.49%) were more often observed in the patients with ACAN heterozygous mutations. Truncating variants had a more severe effect on height, and height was weakly negatively correlated with age at diagnosis. Individuals had received growth-promoting therapy with variable levels of height SDS score improvement.

Conclusion: This study further expands the variation spectrum of the ACAN gene and suggests that facial dysmorphic features are not prominent in Chinese short stature population. In addition, patients who receive growth-promoting treatment before puberty may reap better therapeutic benefits, while also being aware of the duration of treatment.

Volume 95

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sep 2022 - 17 Sep 2022

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.